CD2 Flashcards
Second line in gout prophylaxis
Febuxostat
Gene associated with reactive artritis
HLA-B27
How much to aspirate joint in septic arthritis
To dryness
What test measures lacrimal gland function?
Schirmer test
Serious complication of Sjogrens syndrome
Lymphoma
What are Gottron lesions and what do they indicate?
Scaly red patches on skin and joints indicating dermatomyositis
What to screen for on polymyositis or dermatomyositis
Underlying malignancy
First line in polymyositis or dermatomyositis
Steroids
What triggers guttate psoriasis?
Throat infection
What is plantopalmar psoriasis?
Painful pustules on palms and soles
Score for psoriasis severity
PASI
What test should be done in pemphigus?
Tests for underlying cancer
Bullous pemphigoid treatment
Topical steroids
Oral steroids
Oral abx
Immunosuppressants
Pemphigus treatment
Oral antibiotics or steroids and immunosuppressants
Bowen’s disease presentation
well defined, persistent, inflamed, scaly patches, usually on the legs
Bowen’s disease treatment
Some patients choose not to be treated. If patients do want treatment, this is usually with cryotherapy or topical chemotherapy
Keratoacanthoma definition
lesion similar to an SCC that grows quickly over a few weeks then spontaneously resolves
Keratoacanthoma management
First line treatment is usually excision. Other options include curettage and cautery, radiotherapy and cryotherapy
Keratoacanthoma presentation
a rapidly growing lesion that heals to form a nodule with a crater and a keratin plug usually on sun exposed sites
Keratoacanthoma investigation
Biopsy to exclude SCC
Junctional naevi presentation
Flat and brown
Compound melanocytic naevi presentation
Raised and dark
Intradermal naevi presentation
Raised and flesh coloured
Vitiligo treatment
Not all patients want treatment but some are very keen. Treatments include topical or systemic steroids, phototherapy, and immunosuppressants
What is pityriasis?
Self limiting fungal skin infection
Causes of erythroderma
eczema or psoriasis flare (40%,25%), haematological malignancy (15%), drugs (10%) or in 10% of cases the cause is unknown
Driving in Parkinson’s
Inform DVLA
May be restrictions
Driving after TIA
patients aren’t able to drive cars for 1 month or HGVs for 1 year after a TIA
